Page 89

Gastro_3

Patología Intestinal S 31 Enfermedad de Crohn fi stu lizante periana l - G. Pizarro J. et al. adalimumab therapy in multidisciplinary strategy for perianal Crohn’s disease patients with infliximab failure. J Crohn’s Colitis 2010; 4: 654-60. 34.- Schreiber S, Lawrance IC, Thomsen OO, Hanauer SB, Bloomfield R, Sandborn WJ. Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease-subgroup results from a placebocontrolled study. Aliment Pharmacol Ther 2011; 33: 185-93. 35.- Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. New Engl J Med 2010; 362: 1383-95. 36.- Yarur A, Kanagala V, Stein D, Czul F, Agrawal D, Zadvornova Y, et al. Higher infliximab trough levels are associated with a higher rate of perianal fistula healing in patients with Crohn’s disease. Gastroenterology 2016; 150: S105-S6. 37.- Fichera A, Zoccali M. Guidelines for the surgical treatment of Crohn’s perianal fistulas. Inflamm Bowel Dis 2015; 21: 753-8. 38.- Marzo M, Felice C, Pugliese D, Andrisani G, Mocci G, Armuzzi A, et al. Management of perianal fistulas in Crohn’s disease: an up-to-date review. World J Gastroenterol 2015; 21: 1394- 403. 39.- García-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52: 79-86. 40.- Wainstein C, Quera R, Kronberg U, Conejero A, López-Kostner F, Jofre C, et al. Mesenchymal stem cells and plateletrich plasma in the treatment of patients with perineal Crohn’s disease. Int J Colorectal Dis 2016; 31: 725-6. 41.- El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn’s fistulas. Colorectal Dis 2012; 14: 1217-23. 42.- Bor R, Farkas K, Balint A, Szucs M, Abraham S, Baradnay G, et al. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease-clinical observations from a tertiary Eastern European center. Scand J Gastroenterol 2015; 50: 182-7. 43.- Yassin NA, Askari A, Warusavitarne J, Faiz OD, Athanasiou T, Phillips RK, et al. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn’s disease. Aliment Pharmacol Ther 2014; 40: 741-9. Gastroenterol. latinoam 2016; Vol 27, S upl Nº 1: S 26-S 31


Gastro_3
To see the actual publication please follow the link above